Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 68 | 2023 | 2020 | 12.180 |
Why?
|
Papillomavirus Infections | 34 | 2023 | 1587 | 6.740 |
Why?
|
Uterine Cervical Dysplasia | 19 | 2023 | 387 | 6.090 |
Why?
|
Papillomavirus Vaccines | 17 | 2023 | 491 | 5.570 |
Why?
|
Papillomaviridae | 20 | 2023 | 1119 | 4.080 |
Why?
|
Colposcopy | 14 | 2023 | 144 | 3.630 |
Why?
|
Alphapapillomavirus | 8 | 2022 | 221 | 2.680 |
Why?
|
Early Detection of Cancer | 27 | 2023 | 3086 | 2.500 |
Why?
|
Vaginal Smears | 14 | 2023 | 511 | 2.370 |
Why?
|
Cervix Uteri | 6 | 2021 | 590 | 1.250 |
Why?
|
Mass Screening | 17 | 2023 | 5253 | 1.180 |
Why?
|
Practice Guidelines as Topic | 11 | 2020 | 7282 | 0.980 |
Why?
|
Human papillomavirus 18 | 5 | 2021 | 128 | 0.740 |
Why?
|
Human papillomavirus 16 | 5 | 2021 | 262 | 0.680 |
Why?
|
Vulvar Neoplasms | 2 | 2018 | 272 | 0.660 |
Why?
|
Vaccination | 7 | 2023 | 3279 | 0.630 |
Why?
|
Vaginal Neoplasms | 1 | 2018 | 106 | 0.610 |
Why?
|
Female | 88 | 2023 | 380193 | 0.570 |
Why?
|
Ambulatory Care Facilities | 2 | 2020 | 934 | 0.550 |
Why?
|
Dissection | 1 | 2017 | 295 | 0.540 |
Why?
|
Adenocarcinoma | 6 | 2022 | 6364 | 0.520 |
Why?
|
Fluorouracil | 1 | 2017 | 1619 | 0.440 |
Why?
|
Humans | 91 | 2023 | 744366 | 0.400 |
Why?
|
Appointments and Schedules | 1 | 2015 | 417 | 0.390 |
Why?
|
Referral and Consultation | 4 | 2021 | 3531 | 0.380 |
Why?
|
Laser Therapy | 1 | 2017 | 1072 | 0.380 |
Why?
|
Hysterectomy | 5 | 2016 | 927 | 0.370 |
Why?
|
Carcinoma in Situ | 3 | 2013 | 806 | 0.360 |
Why?
|
Pregnancy | 11 | 2023 | 29144 | 0.360 |
Why?
|
Medical History Taking | 1 | 2013 | 784 | 0.340 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2278 | 0.330 |
Why?
|
Medical Errors | 1 | 2017 | 1297 | 0.330 |
Why?
|
Uterine Hemorrhage | 3 | 1995 | 255 | 0.320 |
Why?
|
Gynecologic Surgical Procedures | 3 | 2023 | 337 | 0.310 |
Why?
|
Electrosurgery | 2 | 2021 | 58 | 0.300 |
Why?
|
Adult | 43 | 2023 | 214052 | 0.300 |
Why?
|
Insurance Coverage | 1 | 2018 | 1900 | 0.280 |
Why?
|
Middle Aged | 40 | 2023 | 213390 | 0.280 |
Why?
|
Cost-Benefit Analysis | 5 | 2023 | 5388 | 0.270 |
Why?
|
Insurance, Health | 1 | 2018 | 2494 | 0.260 |
Why?
|
Precancerous Conditions | 1 | 2011 | 975 | 0.250 |
Why?
|
Massachusetts | 4 | 2018 | 8662 | 0.250 |
Why?
|
Retrospective Studies | 19 | 2023 | 77460 | 0.230 |
Why?
|
Intraoperative Complications | 2 | 2009 | 1198 | 0.230 |
Why?
|
Academic Medical Centers | 4 | 2020 | 2760 | 0.230 |
Why?
|
Young Adult | 15 | 2022 | 56429 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2017 | 9240 | 0.210 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2023 | 3922 | 0.210 |
Why?
|
Risk Assessment | 5 | 2022 | 23336 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3020 | 0.200 |
Why?
|
Healthcare Disparities | 4 | 2022 | 3154 | 0.200 |
Why?
|
Prisons | 1 | 2023 | 161 | 0.190 |
Why?
|
Triage | 3 | 2022 | 977 | 0.190 |
Why?
|
DNA, Viral | 1 | 2006 | 2227 | 0.180 |
Why?
|
Vesicovaginal Fistula | 1 | 2019 | 12 | 0.170 |
Why?
|
Cohort Studies | 11 | 2023 | 40559 | 0.170 |
Why?
|
Neoplasms | 2 | 2018 | 21696 | 0.170 |
Why?
|
Postpartum Period | 2 | 2023 | 1086 | 0.170 |
Why?
|
Aged | 20 | 2022 | 163288 | 0.160 |
Why?
|
Epidermodysplasia Verruciformis | 1 | 2018 | 16 | 0.160 |
Why?
|
Nutrition Surveys | 3 | 2020 | 1660 | 0.160 |
Why?
|
Obstetrics | 2 | 2016 | 658 | 0.160 |
Why?
|
Vulvar Diseases | 1 | 1998 | 61 | 0.160 |
Why?
|
Laparotomy | 2 | 2016 | 473 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 705 | 0.150 |
Why?
|
United States | 12 | 2023 | 69872 | 0.150 |
Why?
|
Administration, Intravaginal | 1 | 2017 | 150 | 0.150 |
Why?
|
Fasciitis, Necrotizing | 1 | 1998 | 79 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 523 | 0.150 |
Why?
|
Endometrial Hyperplasia | 2 | 1995 | 97 | 0.150 |
Why?
|
Developing Countries | 3 | 2016 | 2815 | 0.150 |
Why?
|
Genital Diseases, Female | 1 | 1998 | 197 | 0.150 |
Why?
|
Unsafe Sex | 1 | 2018 | 220 | 0.140 |
Why?
|
Cesarean Section | 2 | 2016 | 1365 | 0.140 |
Why?
|
Mouth Diseases | 1 | 2018 | 241 | 0.140 |
Why?
|
Endometrial Neoplasms | 3 | 1995 | 1351 | 0.140 |
Why?
|
Immunocompromised Host | 2 | 2018 | 847 | 0.140 |
Why?
|
Menopause | 2 | 1994 | 1626 | 0.130 |
Why?
|
Laparoscopy | 2 | 2016 | 2150 | 0.130 |
Why?
|
Health Services Administration | 1 | 2016 | 64 | 0.130 |
Why?
|
Incidence | 6 | 2021 | 20952 | 0.130 |
Why?
|
Demography | 1 | 2020 | 1655 | 0.130 |
Why?
|
Age Factors | 5 | 2018 | 18373 | 0.120 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2015 | 107 | 0.120 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2015 | 246 | 0.120 |
Why?
|
Age Distribution | 1 | 2020 | 2902 | 0.120 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2017 | 640 | 0.120 |
Why?
|
Morbidity | 2 | 2016 | 1768 | 0.120 |
Why?
|
Behavior Therapy | 1 | 2019 | 865 | 0.110 |
Why?
|
Urban Health Services | 1 | 2014 | 179 | 0.110 |
Why?
|
Adrenergic beta-Agonists | 1 | 2015 | 346 | 0.110 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2013 | 96 | 0.110 |
Why?
|
Genes, myc | 1 | 2014 | 399 | 0.110 |
Why?
|
Thromboembolism | 1 | 1999 | 987 | 0.110 |
Why?
|
Follow-Up Studies | 6 | 2023 | 39052 | 0.110 |
Why?
|
Self Disclosure | 1 | 2013 | 251 | 0.100 |
Why?
|
Conization | 1 | 2011 | 14 | 0.100 |
Why?
|
Societies, Medical | 2 | 2016 | 3743 | 0.100 |
Why?
|
Endometrium | 1 | 1994 | 424 | 0.100 |
Why?
|
Rheumatic Diseases | 1 | 2018 | 593 | 0.100 |
Why?
|
Postoperative Complications | 4 | 2023 | 15297 | 0.100 |
Why?
|
Inpatients | 1 | 2023 | 2518 | 0.100 |
Why?
|
Brachytherapy | 1 | 2019 | 1248 | 0.100 |
Why?
|
Rural Health Services | 1 | 2014 | 379 | 0.090 |
Why?
|
Child Abuse, Sexual | 1 | 2013 | 383 | 0.090 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 432 | 0.090 |
Why?
|
Proportional Hazards Models | 2 | 2022 | 12356 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2015 | 1180 | 0.090 |
Why?
|
Health Expenditures | 1 | 2023 | 2349 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 1999 | 1239 | 0.090 |
Why?
|
Arthritis, Rheumatoid | 2 | 2016 | 3712 | 0.090 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2013 | 260 | 0.090 |
Why?
|
Boston | 2 | 2020 | 9312 | 0.090 |
Why?
|
Markov Chains | 1 | 2013 | 969 | 0.090 |
Why?
|
Reoperation | 1 | 2019 | 4201 | 0.080 |
Why?
|
Telomerase | 1 | 2014 | 730 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1405 | 0.080 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 1115 | 0.080 |
Why?
|
Adolescent | 8 | 2022 | 85779 | 0.080 |
Why?
|
Medical Oncology | 2 | 2020 | 2267 | 0.080 |
Why?
|
World Health Organization | 1 | 2014 | 1318 | 0.080 |
Why?
|
Prenatal Care | 1 | 2016 | 1092 | 0.080 |
Why?
|
Quality of Life | 2 | 2020 | 12802 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2649 | 0.080 |
Why?
|
Professional-Patient Relations | 1 | 2013 | 737 | 0.080 |
Why?
|
Photic Stimulation | 1 | 2014 | 2026 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2013 | 15078 | 0.070 |
Why?
|
Cryosurgery | 1 | 2011 | 453 | 0.070 |
Why?
|
Biopsy | 6 | 2023 | 6755 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2016 | 1338 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1998 | 2026 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2488 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 1 | 2013 | 1683 | 0.070 |
Why?
|
Vitamin D | 1 | 2020 | 3224 | 0.070 |
Why?
|
Risk Factors | 10 | 2018 | 72296 | 0.070 |
Why?
|
Prospective Studies | 4 | 2023 | 53290 | 0.070 |
Why?
|
Postmenopause | 1 | 1994 | 2460 | 0.070 |
Why?
|
Palliative Care | 1 | 2020 | 3493 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7785 | 0.070 |
Why?
|
Treatment Outcome | 4 | 2018 | 63107 | 0.060 |
Why?
|
Dilatation and Curettage | 2 | 1994 | 56 | 0.060 |
Why?
|
RNA | 1 | 2014 | 2749 | 0.060 |
Why?
|
Psychotherapy | 1 | 2013 | 1642 | 0.060 |
Why?
|
HIV Infections | 2 | 2021 | 16715 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11031 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 1993 | 1956 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5135 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2018 | 4034 | 0.050 |
Why?
|
Health Resources | 1 | 2009 | 911 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10252 | 0.050 |
Why?
|
Myocardium | 1 | 2015 | 4772 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3841 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2943 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2014 | 2104 | 0.050 |
Why?
|
Heart | 1 | 2015 | 4464 | 0.050 |
Why?
|
Length of Stay | 3 | 2023 | 6311 | 0.050 |
Why?
|
Anxiety | 1 | 2014 | 4293 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4557 | 0.040 |
Why?
|
Angola | 1 | 2019 | 16 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3611 | 0.040 |
Why?
|
Prognosis | 3 | 2013 | 29060 | 0.040 |
Why?
|
China | 2 | 2016 | 2245 | 0.040 |
Why?
|
Pain | 1 | 2014 | 4988 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2014 | 2428 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7914 | 0.040 |
Why?
|
Time Factors | 4 | 2021 | 40075 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2016 | 20824 | 0.040 |
Why?
|
Vulva | 1 | 2018 | 87 | 0.040 |
Why?
|
Botswana | 1 | 2021 | 1040 | 0.040 |
Why?
|
Patient Preference | 2 | 2016 | 889 | 0.040 |
Why?
|
Dental Care | 1 | 2019 | 262 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13104 | 0.040 |
Why?
|
Condoms | 1 | 2018 | 323 | 0.040 |
Why?
|
Polynesia | 1 | 2016 | 13 | 0.030 |
Why?
|
Algorithms | 2 | 2014 | 13882 | 0.030 |
Why?
|
Debridement | 1 | 1998 | 492 | 0.030 |
Why?
|
Rats, Zucker | 1 | 2015 | 128 | 0.030 |
Why?
|
Maternal Mortality | 1 | 1998 | 310 | 0.030 |
Why?
|
Male | 6 | 2023 | 350115 | 0.030 |
Why?
|
Risk | 2 | 2005 | 9688 | 0.030 |
Why?
|
Isoproterenol | 1 | 2015 | 399 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3130 | 0.030 |
Why?
|
Propionates | 1 | 2015 | 169 | 0.030 |
Why?
|
Echocardiography, Stress | 1 | 2015 | 131 | 0.030 |
Why?
|
Professional Practice | 1 | 2016 | 326 | 0.030 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5321 | 0.030 |
Why?
|
HIV | 1 | 2021 | 1604 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3873 | 0.030 |
Why?
|
Psychotherapeutic Processes | 1 | 2013 | 50 | 0.030 |
Why?
|
Clinical Competence | 1 | 2009 | 4687 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15221 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2618 | 0.030 |
Why?
|
Reminder Systems | 1 | 2016 | 371 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 12746 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14723 | 0.030 |
Why?
|
Pelvis | 1 | 2016 | 730 | 0.030 |
Why?
|
Clinical Coding | 1 | 2013 | 171 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13409 | 0.030 |
Why?
|
Signal Transduction | 1 | 2015 | 23404 | 0.030 |
Why?
|
Odds Ratio | 2 | 2014 | 9849 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1221 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 2015 | 502 | 0.020 |
Why?
|
Psychological Tests | 1 | 2013 | 651 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5077 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12244 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2016 | 1262 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19905 | 0.020 |
Why?
|
Office Visits | 1 | 1994 | 598 | 0.020 |
Why?
|
Quinolines | 1 | 2015 | 732 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6539 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2015 | 1579 | 0.020 |
Why?
|
Robotics | 1 | 2016 | 899 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11366 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2016 | 2453 | 0.020 |
Why?
|
Terminal Care | 1 | 2020 | 1694 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2971 | 0.020 |
Why?
|
Rats | 2 | 2015 | 24252 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2014 | 623 | 0.020 |
Why?
|
Health Services Research | 1 | 2016 | 1836 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3616 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2593 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3508 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1164 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 21748 | 0.020 |
Why?
|
Life Expectancy | 1 | 1993 | 1184 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2015 | 1629 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10400 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1438 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 25039 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2016 | 2265 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3476 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9955 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5181 | 0.020 |
Why?
|
Anticoagulants | 1 | 1999 | 4600 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8091 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3553 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6036 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 12961 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8385 | 0.010 |
Why?
|
Health Behavior | 1 | 2014 | 2635 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13991 | 0.010 |
Why?
|
Calcium | 1 | 2015 | 5755 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4153 | 0.010 |
Why?
|
Hospitalization | 1 | 1998 | 10259 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7730 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7721 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2013 | 4468 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8664 | 0.010 |
Why?
|
Animals | 2 | 2015 | 168768 | 0.010 |
Why?
|
Child | 1 | 2013 | 77709 | 0.000 |
Why?
|